Literature DB >> 10582189

Properties of an enzyme-based low-level iodine disinfectant.

Y Duan1, K Dinehart, J Hickey, R Panicucci, J Kessler, W Gottardi.   

Abstract

An enzyme-based iodine (EBI) disinfectant that continuously generates free molecular iodine in a controlled fashion was developed and evaluated for use in disinfecting flexible fibreoptic endoscopes (FFEs). EBI is a powder concentrate that produces iodine from sodium iodide and calcium peroxide when catalyzed by horseradish peroxidase. After dissolution in water, it delivers relatively high concentrations of free molecular iodine (> 15 ppm) at relatively low concentrations of total iodine (30-40 ppm). It demonstrates the ability to function as an effective low level iodine disinfectant by rapidly inactivating bacteria, fungi and viruses. A unique feature of the EBI system is the ability to reoxidize reduced iodine which results in a constant level of active (free molecular) iodine during use. EBI inactivates Mycobacterium bovis var BCG more rapidly than 2% glutaraldehyde (Cidex-7). Its sporicidal activity, however, was found to be slower than the aldehyde formulation. The qualification of EBI for use as a practical disinfectant was shown by its negligible toxicity in dermal, ocular, oral and inhalation studies on animals, which is attributed to the low level of total iodine in the solution.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10582189     DOI: 10.1053/jhin.1999.0249

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  3 in total

1.  Use of a bacteriophage lysin, PlyC, as an enzyme disinfectant against Streptococcus equi.

Authors:  J Todd Hoopes; Caren J Stark; Han Ah Kim; Daniel J Sussman; David M Donovan; Daniel C Nelson
Journal:  Appl Environ Microbiol       Date:  2009-01-09       Impact factor: 4.792

Review 2.  Iodine revisited.

Authors:  Rose A Cooper
Journal:  Int Wound J       Date:  2007-06       Impact factor: 3.315

3.  Molecular iodine is not responsible for cytotoxicity in iodophors.

Authors:  C Freeman; E Duan; J Kessler
Journal:  J Hosp Infect       Date:  2022-02-04       Impact factor: 8.944

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.